Evonik Industries: Global Price Increase of up to 10%
The Business Line Interface & Performance of Evonik is increasing the prices of its products effective October 1, 2014, or as contract allows.
The products of Interface & Performance are sold under the brand names like TEGO® Antifoam, TEGO® RC Silicones, TEGOSIVIN®, TEGOMER®, TEGOPREN®, REWOCOROS®, REWOPOL®, BREAK-THRU®, GETREN®, SITREN®, ADOGEN®, AROSURF® and VARISOFT®.
Prices will be increased by up to ten percent or as contract allows. This measure is needed to compensate for increasing costs during past years in various areas and to support investments aimed at maintaining and improving our availability and supply. Interface & Performance is committed to providing innovative products and technical support that add value for our customers.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.
Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late 1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavour to grow our business in the region. The company now has around 3,200 employees in the Greater China region, the regional sales reached over €1 billion in 2013.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.